Network-1 Technologies, Inc. — Q1 2023 Form 10-Q
Business context and reporting period. The unaudited report covers the three months ended March 31, 2023, compared with the three months ended March 31, 2022. Network-1 develops, licenses, and protects intellectual property, principally through patent licensing and litigation. It also holds an equity-method investment in clinical-stage biotech company ILiAD Biotechnologies.
Key financial results
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Revenue | $537,000 | $0 |
| Operating expenses | $1.313 million | $897,000 |
| Operating loss | $776,000 | $897,000 |
| Net loss | $623,000 | $1.312 million |
| Net loss per share, basic and diluted | $0.03 | $0.05 |
| Net cash used in operating activities | $290,000 | $749,000 |
All Q1 2023 revenue came from settlements involving the expired Remote Power Patent. Operating expenses included $151,000 of settlement-related costs, including $124,000 in contingent legal fees and $27,000 in CEO incentive compensation. Net other income was $674,000, reflecting $310,000 in interest and dividend income and a $364,000 net gain on marketable securities. These amounts were more than offset by the $674,000 share of ILiAD’s net loss. The company recorded a $153,000 deferred tax benefit.
At March 31, 2023, cash and cash equivalents were $9.919 million and marketable securities were $36.920 million, totaling $46.839 million. Working capital was $45.902 million; total assets were $55.380 million and total liabilities were $2.318 million. The filing reports no long-term debt; lease obligations totaled $156,000. Stockholders’ equity was $53.062 million.
Cash decreased by $3.529 million during the quarter. Investing activities used $1.659 million, primarily reflecting purchases of marketable securities; financing activities used $1.580 million, including $1.191 million of dividends and $306,000 of stock repurchases. The board declared a $0.05-per-share dividend, consistent with the company’s stated semiannual dividend policy.
Material changes and business developments
- Revenue increased from zero to $537,000, following settlements with Arista Networks, Antaira Technologies, Panasonic Holdings, and TP-Link USA related to Remote Power Patent litigation. A further conditional $150,000 payment had not been recognized because its conditions were not yet satisfied.
- Operating expenses rose $416,000 year over year, mainly from higher general and administrative expense and settlement-related costs. Despite this, the operating loss narrowed by $121,000; the net loss narrowed by $689,000, aided by improved investment income and marketable-securities results.
- The ILiAD investment’s carrying value fell to $6.578 million from $7.252 million. Network-1 recorded a $674,000 share of ILiAD’s loss, compared with $433,000 a year earlier, using investee results reported on a one-quarter lag. The company has invested $7 million in ILiAD.
- Network-1 repurchased 136,785 shares for approximately $302,000, excluding commissions. Approximately $3.096 million remained available under the repurchase program at quarter-end.
Outlook, risks, and contingencies
Management said existing cash and investments should be sufficient to fund operations for the next 12 months and the foreseeable future. The filing provides no specific revenue or earnings guidance. Management cautions that results may fluctuate substantially because licensing and litigation outcomes, timing of agreements, patent acquisitions, and any return on the ILiAD investment are uncertain.
- Litigation: Google/YouTube Cox Portfolio cases remain pending after summary-judgment motions; no trial date had been set. The appeal of the dismissal of the Meta case was pending. The Netgear royalty dispute remained pending in New York state court. Several Remote Power Patent cases remained unresolved after four settlements.
- Patent portfolio: Of 97 U.S. patents, 52 had expired. The Remote Power Patent expired in March 2020; the company says it receives no licensing revenue for periods after that date and is pursuing claims for alleged pre-expiration infringement. Two Cox patents were due to expire in 2023.
- Revenue concentration: Three parties accounted for 94% of Q1 2023 revenue, all from the Remote Power Patent. Revenue is inherently uncertain and dependent on licensing and litigation activity.
- Investment risk: The company describes the ILiAD investment as significant-risk and uncertain; impairment or continued losses could adversely affect results.
- Tax and dividends: The company could be classified as a personal holding company in 2023 or later, potentially triggering a 20% tax on undistributed personal holding company income or a special dividend that would reduce cash available for operations and strategic activity. The regular dividend policy may be changed by the board.
- The company reported effective disclosure controls, no material change in internal control over financial reporting, and no off-balance-sheet arrangements. It reported $680,000 of cash deposits above FDIC insurance limits.
Important facts for investors to verify
- Whether the $150,000 conditional settlement payment becomes payable and is recognized, and the status and economics of remaining patent cases.
- Whether new licensing revenue can replace revenue from the expired Remote Power Patent, given the concentration and episodic nature of current receipts.
- ILiAD’s financial condition, funding needs, and prospects for a return on Network-1’s investment.
- Cash and marketable-securities balances, future dividends and buybacks, and any potential personal holding company tax or special dividend.
- Future costs and contingent payments tied to patent litigation, portfolio monetization, and the HFT patent acquisition.